"Push for Prior Authorization Reform Gains Momentum with New Federal Rules"
The Biden administration has introduced new rules to limit private health insurance companies' use of prior authorization, aiming to speed up the approval process and require companies to provide specific reasons for denials. While the regulations will impact about 105 million people, they exclude the largest pool of privately insured Americans and do not cover prior authorizations for medications. Patient advocates welcome the rules but argue they don't go far enough to address the issue, citing instances where patients faced significant hurdles to obtain necessary care due to prior authorization denials.
